Prof. Dr. Michael Joner
Academic Career and Research Areas
The Joner Lab is engaged in the translational assessment of innovative diagnostic and therapeutic methods related to obstructive coronary artery disease. Specifically, the research group develops and evaluates novel molecular hybrid intravascular imaging catheters aimed at delineating the functional profile of atherosclerotic coronary plaques next to their morphological characterization.
Prof. Joner studied medicine at the Julius-Maximilians-Universität Würzburg, where he completed his disseration on the topic of integrin regulation during heart failure. During his course, he went on to complete a 2-year fellowship in cardiovascular pathology under the lead of Prof. Virmani in Washington DC. After returning to Germany, he was appointed as W3 professor for early clinical trials and is directing the department for Structural Heart Disease at the German Heart Center Munich.
Awards
- Best Section Editor, EuroIntervention Journal (2021-2022)
- Best Reviewer Award, EuroIntervention Journal (2013)
- Young Investigator Award des CRT Kongresses, Washington DC (2013)
- Award for the best habilitation lecture of the Medical Faculty of the Technical University of Munich (2012)
Key Publications
Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK, Virmani R. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006 Jul 4;48(1):193-202.
AbstractJoner M, Farb A, Cheng Q, Finn AV, Acampado E, Burke AP, Skorija K, Creighton W, Kolodgie FD, Gold HK, Virmani R. Pioglitazone inhibits in-stent-restenosis in atherosclerotic rabbits by targeting MCP-1 and TGF-beta-1. Arterioscler Thromb Vasc Biol. 2007 Jan;27(1):182-9.
AbstractJoner M, Nakazawa G, Finn AV, Quee SC, Coleman L, Acampado E, Wilson PS, Skorija K, Cheng Q, Xu X, Gold HK, Kolodgie FD, Virmani R. Endothelial cell recovery between comparator polymer-based drug-eluting stents. J Am Coll Cardiol. 2008 Jul 29;52(5):333-42.
AbstractJoner M, Morimoto K, Kasukawa H, Steigerwald K, Merl S, Nakazawa G, John MC, Finn AV, Acampado E, Kolodgie FD, Gold HK, Virmani R. Site-specific targeting of nanoparticle prednisolone reduces in-stent restenosis in a rabbit model of established atheroma Arterioscler Thromb Vasc Biol. 2008 Nov;28(11):1960-6.
AbstractMalle C, Tada T, Steigerwald K, Ughi GJ, Schuster T, Nakano M, Massberg S, Jehle J, Guagliumi G, Kastrati A, Virmani R, Byrne RA, Joner M. Tissue characterization after drug-eluting stent implantation using optical coherence tomography. Arterioscler Thromb Vasc Biol. 2013 Jun;33(6):1376-83.
Abstract